This guidance document is aimed at pharmaceutical companies, health professional organisations, Medsafe, the Ministry of Health or individuals who are considering applying to change the legal classification of a medicine in New Zealand. The purpose of this guidance document is to provide general advice on the process for changing the legal classification of a medicine in New Zealand to help ensure the process is easy to understand and transparent.

The document can be found here: www.medsafe.govt.nz

This is the second consultation currently underway with Medsafe - the first is on observers at Ministerial Advisory Committees. Both are due by 15 January.

Feedback due to sueg@nzno.org.nz by 12 January 2018.